3633

antibody from Cell Signaling Technology, Inc

Targeting: ALK CD246

Western blot (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

3633

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#3633, RRID:AB_11127207

Product name

ALK (D5F3®) XP® Rabbit mAb

Antibody type

Monoclonal

Reactivity

Human

Host

Rabbit

Storage

-20°C

References

Submitted references

Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer.

Ren H, Tan ZP, Zhu X, Crosby K, Haack H, Ren JM, Beausoleil S, Moritz A, Innocenti G, Rush J, Zhang Y, Zhou XM, Gu TL, Yang YF, Comb MJ
Cancer research 2012 Jul 1;72(13):3312-23

---

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG, Ou SH, Dezube BJ, Jänne PA, Costa DB, Varella-Garcia M, Kim WH, Lynch TJ, Fidias P, Stubbs H, Engelman JA, Sequist LV, Tan W, Gandhi L, Mino-Kenudson M, Wei GC, Shreeve SM, Ratain MJ, Settleman J, Christensen JG, Haber DA, Wilner K, Salgia R, Shapiro GI, Clark JW, Iafrate AJ
The New England journal of medicine 2010 Oct 28;363(18):1693-703

---

A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry.

Mino-Kenudson M, Chirieac LR, Law K, Hornick JL, Lindeman N, Mark EJ, Cohen DW, Johnson BE, Jänne PA, Iafrate AJ, Rodig SJ
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Mar 1;16(5):1561-71